The proper way to code for the subsequent dilation is based on the timed dilation determined by the urologist. There is no certain amount of time to bill for the subsequent dilation but based on how the dilation will occur, what needs to be done to complete the dilation and when the dilation needs to be performed to increase the size the urethra. If the urologist plans on dilating the patient every week (or every month) using a different sized dilator, then the initial code is billed for the first dilation and then a subsequent dilation code will be used with each visit until the appropriate diameter is achieved. Once that diameter has been achieved and the urologist is satisfied with the results and no other dilation is necessary, then the treatment is concluded. Since the urethra is an elastic channel, it again could become narrower over time and would then justify another treatment session to dilate the urethra again using the initial code and subsequent dilation codes. However, if the urologist plans to dilate the patient every month to maintain the open channel, then the subsequent dilation will be billed monthly until the treatment has been completed and the urethra has been dilated sufficiently.
Of course, if a patient does not return to the office for a three year period and is considered a new patient, the initial dilation code is billed and then visits after that initial dilation would be billed with the subsequent dilation code. The dilation codes are billed based on gender and the type of equipment used to dilate the urethra.
Q. Can multiple bladder biopsies be paid separately?
A. Medicare mandates that only one biopsy will be reimbursed when a series are performed in the bladder. According to the AMA's CPT® Assistant September 2003/ Volume 13, Issue 9, "Code 52204, Cystourethroscopy, with biopsy, should be reported only one time for the procedure, regardless of the number of biopsies performed. If many biopsies are performed, the physician may append modifier -22, Unusual Procedural Services, to the procedure code to indicate that significantly greater time and effort were required to perform the procedure. Documentation should be provided explaining the circumstances of the procedure and the extra effort required."
Some commercial carriers, however, may reimburse for more than one biopsy site. Check with your carrier for their policy. If more than one biopsy is allowed, append modifier -51, Multiple Procedures.
Q. Our urologist had to convert a laparoscopic procedure to an open procedure due to complications. How do we bill this?
A. Under Medicare if a laparoscopic procedure is converted to an open procedure, you may only bill the open procedure. Some commercial carriers will allow billing of the laparoscopic procedure with modifier -52, Reduced Services, or -53, Discontinued Procedure, plus the open procedure code. Effective October 1, 2003 there is a new ICD-9-CM diagnosis code V64.41, Laparoscopic surgical procedure converted to open procedure that should be used as a secondary diagnosis code.
Q. How do you bill for a hand-assisted laparoscopy procedure?
A. There is no special code for hand-assisted laparoscopy procedures. Use the appropriate specific laparoscopy CPT® code for the procedure or the unlisted laparoscopy CPT® codes for the appropriate organ. If there is no unlisted laparoscopy code, use code 53899, Unlisted procedure, urinary system.
Q. The urologist performed a hernia repair and an orchiopexy. How can I bill for these procedures?
A. Bill both orchiopexy by inguinal approach (54640) along with inguinal hernia repair codes (49495-49525) if performed during same operative session. The AMA CPT® Assistant in January 2004 stated that it is completely appropriate to bill these two codes if performed during the same operative session.
Q. My urologist is injecting botulinum toxin, type A into the bladder for spasms. What is the proper way to code for this procedure?
A. There is no specific CPT® code for the injection of botulinum toxin into the bladder. CPT® code 53899 should be used to capture this procedure. The HCPCS code is J0585. Since the use of this treatment is not approved by the FDA, some carriers will not reimburse for this due to its off-label use. Check with the carrier for any specific coverage questions. It may be necessary to have the patient sign an ABN in order to bill the patient for the treatment.
Revised! (8/06)
Q. Which CPT® codes do I use for Fournier's gangrene (necrotizing facititis)?
A. As of January 1, 2005, there are several new codes for the removal of Fournier's gangrene. They are:
11004 Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue infection of external genitalia and perineum
11005 abdominal wall, with or without fascial closure
11006 Debridement of skin, external genitalia, perineum and abdominal wall, with or without fascial closure
Skin grafts or flaps harvested separately for closure when performed at the same session as 11004-11008 should be billed separately.
There is also an add-on code which may be used in addition to the debridement codes:
11008 Removal of prosthetic material or mesh
In 2006, there was parenthetical information added to include:
(When insertion of mesh is used for closure, use 49568.)
These procedures have a 0 global period so these codes may be billed each day the patient is taken to the operating room for further removal of necrotic tissue.
Q. After performing a partial nephrectomy, the frozen section sent to pathology indicated involvement of the margins with the malignant tumor. A radical nephrectomy was performed that same day during the same surgical case. How should this be coded?
A. Bill the partial nephrectomy with CPT® code 50240 and then bill the nephrectomy with CPT® code 50220. If a regional lymphadenectomy was performed, then bill 50230. Either of these two nephrectomy codes (50220-50230) should be billed with a -58 modifier to indicate that these procedures were more extensive than the original due to the results of the pathology report. Make sure documentation supports the staged procedure.
New! (4/07)
Q. How do I bill for the implantation of a fiduciary marker in the prostate for radiation therapy guidance?
A. As of January 1, 2007, use new CPT code 55876 Placement of interstitial device(s) for radiation therapy guidance (eg, fiducial markers, dosimeter), prostate (via needle, any approach), single or multiple to bill the placement of ficuciary markers. Also bill the 76942 Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation for the placement of these devices. The gold seeds or other markers are not reimbursable separately through Medicare. Commercial carriers may reimburse for the seeds/markers if an invoice is attached. These carriers may pay for the seeds or markers, using A4649 or 99070. Check with your carrier on this procedure.
New! (8/06)
Q. What is the proper code to bill for a subureteric transureteral injection (STING) procedure for reflux?
A. Use CPT® code 52327 cystourethroscopy (including ureteral catheterization); with subureteric injection of implant material. There is no established HCPCS code for the dextranomer/hyaluronic acid copolymer. Use the prothesis implant, not otherwise specified HCPCS code L8699. Submit a copy of the invoice for reimbursement.
New! (8/06)
Q. How do you bill for laparoscopic prostatectomy and laparoscopic lymphadenectomy performed at the same operative session?
A. Use CPT® codes
55866 Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing
and
38571 Laparoscopy, surgical; with bilateral total pelvic lymphadenectomy
Revised (5/07)
Q. Is there a CPT® code available to bill for a Martius flap in conjunction with a urethrovaginal fistula?
A. Use CPT® code 57311 Closure of urethrovaginal fistula with bulbocavernosus transplant. Append the 52 modifier since bulbocavernosus transplant was not peformed.
If a repair of a vesicovaginal fistula w/flap is performed, use 57320 Closure of vesicovaginal fistula, vaginal approach and 20926 Tissue grafts, other (eg paratenon, fat, dermis) for flap harvesting.
New! (8/06)
Q. Is it necessary to append a 52 modifier if a adrenalectomy is not performed during a radical nephrectomy?
A. The answer is no. Because of the difficulty to maintain the adrenal gland during a nephrectomy, a modifier 52 is not necessary. If the adrenal gland can be left in place, it is more beneficial to the patient.
New! (8/06)
Q. How do I bill for ablation of renal tumor(s)? Can I bill for each tumor ablated?
A. There were several new codes developed by CPT® for ablation of renal tumors. Bill for the appropriate method of ablation.
50250 Open, cryosurgical, including ultrasound
50592 Percutaneous, radiofrequency
0135T Percutaneous, cryotherapy
According to the descriptor for each codes the tumor has an additional parenthetical (s), which means one or more than one. Because of this parenthetical, each of these codes can be billed only once no matter how many tumors are removed from the kidney. However, if you perform this surgery bilaterally, append the 50 modifier.
Please note that neither 50592 nor 0135T include image guidance and monitoring. If performed and documented, the imaging guidance and monitoring should be additionally reported with 76362, 76394 and 76940 depending on the type of guidance. CPT® 50250 cannot be billed with an additional ultrasound code.
New! (8/06)
Q. If a radical cystectomy is performed on a male and the prostate is removed in the same session are they coded separately? What about a cystectomy and hysterectomy in a female?
A. In males, when a radical prostatectomy is performed in addition to radical cystectomy during the same operative session, both procedures may be billed. The CPT® code 55840 "prostatectomy; retropubic radical, with or without nerve sparing" can be billed with a -51 modifier in addition to the appropriate cystectomy code. In females, when a removal of uterus and/or tubes and ovaries is performed in addition to the radical cystectomy, CPT® code 58150 "total abdominal hysterectomy (corpus and cervix) with or without removal of tube(s), with or without removal of ovarie(s)" with a -51 modifier may be billed in addition to the cystectomy code.
Use the appropriate CPT® code from the following list of cystectomy procedures as the primary procedure:
51570 Cystectomy, complete; (separate procedure)
51575 with bilateral pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes
51580 Cystectomy, complete, with ureterosigmoidostomy or ureterocutaneous transplantations:
51585 with bilateral pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes
51590 Cystectomy, complete, with ureteroileal conduit or sigmoid bladder, including bowel anastomosis;
51595 with bilateral pelvic lymphadenectomy, including external iliac, hypogastric, and obturator nodes
51596 Cystectomy, complete, with continent diversion, any technique, using any segment of small and/or large bowel to construct neobladder
New! (8/06)
Q. A patient who had a cystectomy with ileal conduit is now having problems, which require the physician to visualize the conduit. Is there a code for an endoscopy through a stoma into the ileal loop?
A. Yes, use CPT® Code 44380 Ileoscopy, through stoma; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure) for the visualization of the conduit.
New! (8/06)
Q. Another patient had a cystectomy with a continent diversion. How do I bill for an endoscopy into the pouch?
A. Use CPT® code 44385 Endoscopic evaluation of small intestinal (abdominal or pelvic) pouch; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure).
New! (8/06)
Q. How do I bill for stent insertion in either an ileal conduit or a continent diversion?
A. Use CPT® code 44383 Ileoscopy, through stoma; with transendoscopic stent placement (include predilation) for the ileal conduit. For stent insertion into a continent diversion, use CPT® code 44385 Endoscopic evaluation of small intestinal (abdominal or pelvic) pouch; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure) with a 22 modifier since there is no specific CPT® code for the stent insertion in this situation.
New! (8/06)
Q. How do I bill for the revision of the stoma? The patient had a prior ileal conduit and the stoma is starting to close.
A. Use CPT® Code 44312, Revision of ileostomy; simple (release of superficial scar) (separate procedure) or 44314, Revision of ileostomy; complicated (reconstruction in-depth) (separate procedure). Use the 44314 if a revision of the ileal conduit must be performed at a later date.
New! (8/06)
Q. The urologist performed a transrectal ultrasound on a patient prior to a transurethral needle ablation (TUNA), transurethreal microwave thermotherapy (TUMT) or interstitial laser coagulation (ILC) procedure to determine the size of the prostate. He describes this as a "prostate volume study." How do I code for this?
A. The performance of a transrectal ultrasound prior to a TUNA is not considered a "prostate volume study." A true prostate volume study includes 5 mm cuts and views. There is a CPT® code for a prostate volume study performed prior to brachytherapy treatment. However, to code for a TRUS prior to TUNA, use CPT® code 76872, Transrectal ultrasound, prostate.
New! (8/06)
Q. Can I charge for supplies used during surgical procedures in my office (eg, biopsy needles, catheters)?
A. When a CPT® code is established, there are three components: the physician's work, malpractice and practice expense. These components are then added together to establish the relative work values or the amount you can be reimbursed for the procedure. The practice expense portion of the RVU includes all the supplies necessary to perform the procedure and the equipment necessary to perform the procedure. Therefore, you cannot bill the use of supplies for the performance of surgical procedures.
New! (8/06)
Q. Is there any way to be reimbursed for a digital rectal examination under anesthesia?
A. In 2006, a new CPT® code was developed to capture a DRE under anesthesia. Use CPT® code 45990 Anorectal exam, surgical, requiring anesthesia (general, spinal, or epidural) diagnostic. The examination includes the following components: external perineal exam, digital rectal exam, pelvic exam (when performed), diagnostic anoscopy and diagnostic rigid proctoscopy. If any of the components are not performed, append a
-52 modifier. If any other procedure is performed following the anorectal examination under anesthesia, then you cannot bill the 45990.
New! (8/06)
Q. There have been some new codes developed for the stent insertion and removals that require some type of radiological guidance. What are the new codes?
A.
50382 Removal and replacement of internal ureteral stent via percutaneous approach*
50384 Removal of internal ureteral stent via percutaneous approach*
50387 Removal and replacement of external transnephric ureteral stent**
50389 Removal of nephrostomy tube**
* with radiological supervision and interpretation
** requires fluoroscopic guidance
If any of these procedures are done bilaterally, append a 50 modifier.
New! (8/06)
Q. Is it appropriate to bill a prostatic dilation (CPT® 52510) prior to transurethral microwave therapy (CPT® 53850)?
A. The answer is no. It is not appropriate to bill the dilation prior to TUMT. If dilation is necessary to complete the procedure, then the dilation is bundled into the major procedure performed.
Minimally Invasive BPH Procedures
Revised! (8/06)
Q. How do you code for photoselective vaporization of the prostate (PVP) for the diagnosis of BPH?
A. In Coding Tips for the Urologist's Office 2003, the chapter on "Coding Yet Another BPH Therapy" states that the method of destruction of tissue should drive the use of the most appropriate CPT® code. Since PVP uses laser light pulses that quickly and hemostatically vaporize and remove the prostatic obstruction completely and leave an open urethral channel, CPT® code 52648, Laser vaporization with or without transurethral resection of the prostate, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included) is recommended by the AUA.
Q. Does the patient have to be in total urinary retention to use the "with urinary obstruction" code for BPH?
A. No, the patient doesn't have to be in total retention to use the "with urinary obstruction" code, however, the patient should have some type of urinary obstructive symptoms. The National Center for Health Statistics (NCHS) added "with urinary obstruction" and "without urinary obstruction" to the BPH diagnosis codes due to questions when a patient has both BPH and obstruction or retention. According to a NCHS official, there was a "debate as to which diagnosis should be sequenced first. The combination code negates the sequencing battle."
Revised! (4/07)
Q. There are several different diagnosis codes for BPH. What is the difference between hypertrophy and hyperplasia?
A. The BPH diagnosis codes are:
600.00 |
|
Hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract (LUTS) |
600.01 |
|
Hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (LUTS) |
600.20 |
|
Benign localized hyperplasia of prostate without urinary obstruction and other lower urinary tract symptoms (LUTS) |
600.21 |
|
Benign localized hyperplasia of prostate with urinary obstruction and other lower urinary tract symptoms(LUTS) |
600.90 |
|
Hyperplasia of prostate, unspecified, without urinary obstruction and other lower urinary symptoms (LUTS) |
600.91 |
|
Hyperplasia of prostate, unspecified, with urinary obstruction and other lower urinary symptoms (LUTS) |
Hyperplasia is excessive proliferation of normal cells in the normal tissue arrangement of an organ. Hypertrophy is an increase in the size of an organ or structure. Either way, the prostate size is increased which could cause urinary complications. According to the NCHS, the two hyperplasia codes and the one hypertrophy code can be used interchangeably. NCHS advises the use of the diagnosis code that fits the terminology the physician uses.
back to top
Radiological Procedures
Q. Is CPT® code 76000, Fluoroscopy (separate procedure), up to one hour physician time, other than 71023 or 71034 (e.g., cardiac fluoroscopy) inherent in CPT® code 50590, Lithotripsy, extracorporeal shock wave?
A. Yes, according to CCI edits version 9.2, which went into effect July 1, 2003, fluoroscopy has been bundled into ESWL. This means for Medicare claims, modifier -59, Distinct procedural service, must be appended to code 76000 to receive reimbursement. There must be a medically necessary reason for the use of fluoroscopy apart from locating the stone for the lithotripsy.
Q. My urologist performs retrograde pyelograms CPT® code 52005 in conjunction with many cysto/ureteroscopy procedures. Can I bill separately for the retrogrades?
A. According to the CCI edits, retrograde pyelograms are bundled into cystoscopy codes 52320 through 52355 and cannot be unbundled under any circumstances. If the retrograde is performed to complete the procedure, CCI considers the retrograde inherent to the endoscopy procedure performed. However, if the physician performed the supervision and interpretation of the retrograde, the urologist may bill the 74420 urography, retrograde, with or without KUB. If the physician does not own the equipment, a -26 modifier must be appended to the 74420. A complete and separate report must be dictated with findings.
Q. Is a separate report required for diagnostic testing (such as transrectal ultrasound, renal ultrasound, post-void residual)?
A. Yes, all CPT® services (E&M, procedures and radiology) must be documented. The AMA clarified this issue in the E&M Services Guidelines Section in the CPT® book. The language reads:
"The actual performance and/or interpretation of diagnostic tests/studies ordered during a patient encounter are not included in the levels of E&M services. Physician performance of diagnostic test/studies for which specific CPT® codes are available may be reported separately, in addition to the appropriate E&M code. This physician interpretation of the results of diagnostic tests/studies with preparation of a separate, distinctly identifiable signed written report may also be reported separately, using the appropriate CPT® code with the modifier -26, Professional Component, appended."
However, many insurance companies, including Medicare, will not pay for both the radiologist's interpretation of a diagnostic study and for the physician who reads and interprets the results of a diagnostic test performed outside the physician's office. If the physician performs the procedure and interprets the result, coordinate billing on this with the hospital. The hospital should bill for the technical component (-TC) and the physician should bill for the professional component (-26).
If the tests/studies are performed in the physician's office, bill the CPT® code for the actual test. No modifiers breaking out the technical and professional components are necessary. A separate written report is required for the patient's chart.
Q. If an ultrasound is performed on a male, what must be evaluated for it to be considered a complete study?
A. In order to bill a 76856 Ultrasound pelvic (nonobstetric), B-scan and/or real time with image documentation; complete evaluation & measurement (when applicable) of the urinary bladder, evaluation of prostate and seminal vesicles (visualized transabdominally), and any pelvic pathology (bladder tumor, enlarged prostate, free pelvic fluid, pelvic abscess) must be performed and documented.
Q. Can I bill for both an abdominal ultrasound and pelvic ultrasound if the urologist evaluates the kidneys and bladder?
A. You cannot bill for both a 76705 Ultrasound abdominal, B-scan and/or real time with image documentation; limited (eg, single organ, quadrant, follow-up) and a 76857 Ultrasound, pelvic (nonobstetric), B-scan and/or real time with image documentation, limited or follow-up (eg, for follicles) when each of these organs is evaluated. CPT® code 76770 Ultrasound, retroperitoneal (eg, renal, aorta, nodes), B-scan and/or real time with image documentation, complete should be billed if the clinical history suggests urinary tract pathology, and evaluation of both kidneys & bladder.
Revised! (8/06)
Q. How do I bill for low osmolar contrast material used when performing CT scans?
A. Use the following HCPCS codes when billing the low osmolar contrast material necessary for patients with allergies.
Q9945 Low osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
Q9946 Low osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
Q9947 Low osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
Q9948 Low osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
Q9949 Low osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
Q9950 Low osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
Q9951 Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
back to top
Skilled Nursing Facility
Q. How can I be sure that I will be reimbursed for services provided for the patients residing in a SNF and requested by the facility staff?
A. To address this, CMS recently clarified the requirements that must be met for a Medicare SNF to have a valid "arrangement" in effect with an outside supplier. This "arrangement" must constitute a written arrangement to reimburse the outside entity for Medicare-covered services subject to consolidated billing, i.e. services that are reimbursable only to the SNF as part of its global prospective payment system per diem or those Part B services that must be billed by the SNF.
CMS also plans to post more information on its web site, develop sample written arrangements and implement a computerized system that will allow Part B suppliers to check Part A eligibility prior to billing.
Services such as luteinizing hormone—reducing hormone (LH-RH) injections, the technical component of urodynamics testing, urinalysis, biofeedback, and laboratory work performed on patients residing in the SNF must be reimbursed through the SNF itself.
Medicare has also addressed the "arrangement" between the SNF and the supplier (physician) of services provided to SNF patients. Transmittal 183 (dated May 21) Medicare Claims Processing Manual Pub. 100-04 for Skilled Nursing Facility Consolidated Billing, published by CMS, outlines detailed background on SNF agreements, what is excluded from consolidated billing and what is necessary to secure proper reimbursement for services performed on SNF patients.
The main directive in this transmittal is that "The SNF and the supplier of services (anyone who provides services to a skilled nursing facility patient other than the SNF itself) must have their "arrangement" in writing." The arrangement should specify what services will be provided by the supplier, how the supplier is to be paid and the reimbursement amount for the services, as well as a means of resolution if there is a dispute over a particular service.
No agreement, no payment
If an agreement is not in writing between the supplier (physician) and the SNF, physician services will not be reimbursed if inappropriately billed to the Part B carrier. A letter requesting repayment to the Medicare program could also result. Most importantly, the inappropriate submission of these claims could result not only in payment denials but might also cause civil monetary penalties for improper billing.
The SNF also risks violating the terms of the Medicare provider agreement (which requires a SNF to have a valid arrangement in place whenever a resident receives services not subject to consolidated billing from any entity other than the SNF itself) and removal from the Medicare program.
It is vitally important to have a written agreement with a SNF when services are provided to SNF patients that are subject to consolidated billing. For more information on this subject visit the CMS web site at www.cms.hhs.gov/MLNMattersArticles/downloads/MM3248.pdf and choose Transmittal R183CP.
Tips for treatment of SNF patients
- Have a written agreement with the SNF that outlines services provided, amount of reimbursement, billing procedures, and who to call to verify information, where to bill, what happens if incorrect information is provided to the supplier, and a means of resolution if there is a problem with services provided as a result of the incorrect information.
- When the SNF call for an appointment, verify the status of the SNF patients. These patients are covered under Part A for the first 100 days of residence in a SNF. Get the name of the contact person and the verification of coverage. If this information proves to be incorrect, then the written agreement should have a clause to cover payment.
- Sometimes a family member may remove a patient from the SNF for a brief leave of absence and may try to arrange physician services without the knowledge of the SNF or does not relay that information to the office staff. It is necessary to check with this family member to ascertain whether the patient is a resident of the SNF. This is a more difficult situation for office staff.
- Make sure you know the status of the patient that comes into your office. When a patient is scheduled for an appointment, make sure a question is asked. "Is this patient a resident of a SNF?" If the answer is yes, unless you have a written agreement with the SNF, then the urologist shouldn't provide anything except professional services, i.e., office visits, minor office procedures, etc. Check CMS web site at www.cms.hhs.gov/physician for a list of excluded services for SNF patients.
- Make sure physicians and staff understand the important of verifying this information.
Q. Can we be reimbursed for a cystoscopy performed on a Skilled Nursing Facility (SNF) patient who is brought to our office for evaluation?
A. Yes, a cystoscopy will be reimbursed through Medicare Part B. Many urological procedures performed in the office on SNF patients will be reimbursed through Medicare Part B. For more information on the definition and regulations pertaining to SNF patients, refer to the chapter on Skilled Nursing Facility Patients in this publication.
Q. One of our patients lives in a SNF. He is transported to the office for monthly leuprolide acetate or goserelin acetate injections. We supply the medications but Medicare is now requesting reimbursement for these injections because the patient lives in a skilled facility. Is this appropriate?
A. According to the regulations, only the SNF can bill and be reimbursed for certain services and supplies (including drugs). The physician must make arrangements with the SNF for care, the SNF will bill Medicare Part A and then the SNF reimburses the physician according to those arrangements. Only the SNF can bill Medicare Part A.
Some drugs are excluded from this Part A reimbursement rule. However, injections of prostate cancer treatment drugs are not on the excluded list. Therefore, reimbursement of the prostate cancer treatment drugs are only reimbursed to the SNF. The new requirements can be downloaded from the CMS web site. Again, refer to the chapter on Skilled Nursing Facilities for more details.
It is recommended in this case that a written legal contract be written for the physician to be reimbursed through the SNF or have the SNF arrange acquisition and administration of the chemotherapy. See the chapter on SNF patients for a more complete explanation of the Medicare requirements.
back to top
Denials for PSA
Revised! (8/06)
Q. Why am I getting denials for PSA's?
A. Medicare's November 25, 2002 implementation of a National Coverage Determination (NCD) for prostate-specific antigen (PSA) resulted in numerous denials for PSA's. Medicare released a list of diagnosis codes it would cover when billed with CPT® code 84153, Prostate specific antigen (PSA); complexed (direct measurement); total. The NCD went into effect November 2002. It replaced all existing local medical review policies. CMS will update covered diagnosis codes whenever necessary by quarterly updates to NCDs.
Medicare will automatically deny payment when CPT® code 84153 is billed with a non-covered ICD-9 code. Covered ICD-9 diagnoses are shown in the table below:
- 185 Malignant neoplasm of prostate
- 188.5 Malignant neoplasm of bladder neck
- 196.5 Secondary and unspecified malignant neoplasm of lymph nodes of inguinal region and lower limb
- 196.6 Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
- 196.8 Secondary and unspecified malignant neoplasm of lymph nodes of multiple sites
- 198.5 Secondary malignant neoplasm of bone and bone marrow
- 198.82 Secondary malignant neoplasm of genital organs
- 233.4 Carcinoma in situ of prostate
- 236.5 Neoplasm of uncertain behavior of prostate
- 239.5 Neoplasm of unspecified nature of other genitourinary organs
- 596.0 Bladder neck obstruction
- 599.60 Urinary obstruction, unspecified
- 599.69 Urinary obstruction, NEC
- 599.7 Hematuria
- 600.01 Hypertrophy (benign) of prostate with urinary obstruction
- 601.9 Prostatitis, unspecified
- 602.9 Unspecified disorder of prostate
- 788.20 Retention of urine unspecified
- 788.21 Incomplete bladder emptying
- 788.30 Urinary incontinence, unspecified
- 788.41 Urinary frequency
- 788.43 Nocturia
- 788.62 Slowing of urinary stream
- 788.63 Urgency of urination
- 790.93 Elevated prostate specific antigen, (PSA)
- 793.6 - 793.7 Nonspecific abnormal findings on radiological and other examination of abdominal area, including retroperitoneum and musculoskeletal system
- 794.9 Nonspecific abnormal results of specified function studies, other
- V10.46 Personal history of malignant neoplasm, prostate
CMS is currently considering adding the following codes to the NCD for Laboratory Services for PSA:
600.10 Nodular prostate without urinary obstruction
600.11 Nodular prostate with urinary obstruction
600.21 Benign localized hyperplasia of prostate with urinary obstruction
According to the narrative in CMS' Decision Memo/Tracking Sheets for the indications of PSA testing:
PSA is of proven value in differentiating benign from malignant disease in men with lower urinary tract signs and symptoms (e.g., hematuria, slow urine stream, hesitancy, urgency, frequency, nocturia and incontinence) as well as with patients with palpably abnormal prostate glands on physician exam, and in patients with other laboratory or imaging studies that suggest the possibility of a malignant prostate disorder.
These codes may become effective in August 2006.
This NCD does not affect the screening PSA test, allowed once a year as a Medicare benefit. The screening PSA is billed with HCPCS code G0103, Prostate cancer screening; PSA total and diagnosis code V76.44, Special screening for malignant neoplasms; prostate.
back to top
Miscellaneous
Q. Is there a diagnosis code for penile fracture?
A. Use ICD-9-CM diagnosis code 959.13, Fracture of corpus cavernosum penis. This code was implemented October 1, 2003.
Q. How do I code for a patient's condition when I have not determined a diagnosis?
A. When you see a patient and cannot immediately determine a final diagnosis without lab results or other pending information, code the visit with ICD-9 coding, indicating the signs and/or symptoms that prompted ordering the test. Do not bill with an unconfirmed, possible diagnosis. Once the test results have been determined, then bill any subsequent visits with the confirmed ICD-9 diagnosis code. If the diagnostic test results are normal, use ICD-9 codes for the signs and/or symptoms that prompted the treating physician to order the study.
Q. How do I code for a prostate smear without a stain?
A. There are two appropriate codes: HCPCS code Q0111, Wet mounts, including preparations of vaginal, cervical or skin specimens and CPT® code 87210, Smear, primary source with interpretation; wet mount for infectious agents (e.g., saline, India ink, KOH preps). Q0111 can only be reported if the physician performing the test has received CLIA certification for Physician Performed Microscopy Procedures. CPT® Code 87210 is a waived test through CLIA.
If you are performing the stain, use CPT® code 87205, Smear, primary source with interpretation; Gram or Giemsa stain for bacteria, fungi or cell types.
Note: To obtain information on the certification process, visit the CMS web site or contact your state health department.
Q. When do I stop using the cancer ICD-9 codes and begin using the personal history V codes on a patient I treated for cancer?
A. You should use the cancer diagnosis as long as the patient is under active treatment. At the end of the treatment, if there are no signs and symptoms of the cancer, you may begin using the V codes. But there are exceptions. If the patient is taking cancer-suppressing drugs, continue to use the cancer ICD-9 codes, as the cancer is only under control and is not gone. The assignment of the diagnosis of cancer is under the judgment of the physician.
Q. Can I bill for a urinalysis and bladder scan during the postoperative period?
A. During the postoperative period, any type of laboratory/pathology or radiological procedure should be reimbursed by the insurance carrier. For Medicare, the reason that these types of services are allowed is because they have an "XXX" global which states that "the global concept does not apply to this code." Therefore they are not bundled into the global period of a surgery. There has been a problem with CPT® code 51798, Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging, in the last year because it was moved to the Urinary System Section of CPT®. Some carriers are mistaking this for a surgical procedure when it is clearly a radiological procedure and carries the "XXX" global. It may be necessary to appeal these types of claims with your insurance carrier.
Q. Is CPT® going to create a code for robotic assisted laparoscopic procedures?
A. There has been some discussion at the AMA regarding a new CPT® code for robotic assisted laparoscopic procedures, however, presently no code exists. In the meantime, use the appropriate laparoscopic CPT® procedure code. If a significant amount of additional time is incurred during the procedure and the operative report outlines this additional time, append modifier -22, Unusual Procedural Services. Another option may be to use the unlisted laparoscopic code. Check with carriers to see if there is a policy on this procedure.
Q. Our urologist dictates the office notes and gives them to our transcriptionist. At the end of the notes, the transcriptionist types "Dictated but not read." The doctor does not review or sign the dictation. Will this pass an audit?
A. No. As any audit is based on documented notes in a patient's chart, the physician is responsible for the accuracy of his dictated material. The urologist must read and sign all documents in the patient's chart not only for medical and auditing reasons, but also for legal reasons.
Q. Our patient saw his urologist and internist on the same day - two entirely different physicians in two different practices. The claim for the urologist was denied. Can we appeal this decision?
A. Yes, this is definitely a case where an appeal should be pursued. Submit a cover letter with your appeal and outline the reason for the visit, medical necessity, and ask that this claim be reconsidered.
Q. What is the diagnosis code for Peyronie's disease?
A. As of October 1, 2003, a new ICD-9-CM diagnosis code, 607.85, was established for Peyronie's disease.
New/Revised! (8/06)
Q. I understand that Medicare deleted the G codes for drug administration in January, 2006. What codes do I use in their place?
A. Medicare Drug Administration Changes
Injections and Infusions |
|
New 2006 CPT® Code |
2005 G Code |
Descriptor |
Urology Example |
90765 |
G0347 |
Intravenous infusion, for therapy/diagnosis; initial, up to one hour |
Zoledronic acid for injection (Zometa J3487) |
90767 |
G0349 |
Intravenous infusion, for therapy/diagnosis; additional sequential infusion, up to one hour |
For any drug given after the initial infusion |
90766 |
G0348 |
Intravenous infusion, for therapy/diagnosis; each additional hour, up to eight (8) hours |
For any drug given after the second infusion up to 8 hours |
90768 |
G0350 |
Intravenous infusion, for therapy/diagnosis; concurrent infusion |
For any drug given at the same time as initial infusion |
90772 |
G0351 |
Therapeutic or diagnostic injection; subcutaneous or intramuscular |
Testosterone (J3150) |
90774 |
G0353 |
Therapeutic or diagnostic injection; intravenous push, single or initial substance/drug |
Gentamycin (J1580) prior to cysto for patient with prosthesis |
90775 |
G0354 |
Therapeutic or diagnostic injection; each additional sequential intravenous push |
Any additional drug with G0353 same session |
90772 |
N/A |
Intramuscular injection of antibiotic |
Penicillin (J0350) |
90779 |
N/A |
Unlisted injection or infusion |
|
96402 |
G0356 |
Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic |
Leuprolide acetate (Lupron J9217), Goserelin acetate (Zoladex J9202), Abarelix (Plenaxis J0128), Triptorelin pamoate (Trelstar J3315) |
This is not an inclusive list of all the G code changes but only the ones that affect urology. For a more detailed listing of the changes, as well as complete guidelines, please see the 2006 CPT® manuals or click here. The CPT® codes are effective for all carriers both Medicare and Commercial carriers.
Q. Can I bill a 99211 "nurse" visit with the chemotherapy administration code?
A. No. The lowest level E/M service 99211 will not be reimbursed with the chemotherapy administration code.
Q. Will a -25 modifier still be required when an E/M Service (99212-99215 or 99202-99205) is provided on the same day with chemotherapy administration?
A. As of 1/1/04 if an evaluation and management service is provided by the physician or other Medicare approved healthcare provider (PA/NP) on the same day as the chemotherapy injection, then the E/M service must have the -25, Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service modifier appended to it. Make sure your documentation describes the medical necessity of the evaluation and management service provided.
Revised! (8/06)
Q. I have a patient who has anemia and fatigue as a side effect of his prostate cancer. The urologist is prescribing an epoetin alfa (Procrit) injection. How do I bill for this?
A. According to the manufacturer, if the hematocrit is less than or equal to 36 and hemoglobin is greater than 12, epoetin alfa (Procrit) will be covered. Check with your specific carrier for coverage determinations and pay close attention to the documentation requirements in the LCD.
Bill the anemia diagnosis code (285.9) and the chemotherapy encounter code (V58.1) when you give a epoetin alfa (Procrit) injection.
Bill the Procrit injection using 90772 for both commercial carriers and for Medicare patients. The drug is HCPCS code J0885 injection, epoetin alfa (for non-ESRD use), 1000 units.
If you are performing an E/M service with the injection, you can bill an E&M with a -25 modifier.
If you are administering an LH-RH agonist (leuprolide acetate or goserelin acetate) on the same day, then bill the 96402 for commercial carriers and Medicare with ICD-9 "185" and the E/M with a modifier -25.
Q. A patient is scheduled for a cystocele repair. What is the diagnosis code for cystocele?
A. There are new ICD-9-CM codes that were created effective October 1, 2004 that replaced and more specifically defined diagnosis codes for prolapse. They are as follows:
618.00 |
|
Unspecified prolapse of vaginal walls Vaginal prolapse NOS |
618.01 |
|
Cystocele, midline Cystocele NOS |
618.02 |
|
Cystocele, lateral Paravaginal |
618.03 |
|
Urethrocele |
618.04 |
|
Rectocele Proctocele |
618.05 |
|
Perineocele |
618.09 |
|
Other prolapse of vaginal walls without mention of uterine prolapse Cystourethrocele |
618.81 |
|